| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cautionary view on blood pressure lowering in patients with acute ischaemic stroke receiving reperfusion therapy
|
Kruyt, Nyika D
|
|
|
24 |
1 |
p. 28-29
|
artikel
|
| 2 |
Advances in dementia research and clinical care in 2024
|
Benzinger, Tammie
|
|
|
24 |
1 |
p. 8-9
|
artikel
|
| 3 |
Advances in neuromuscular disorders 2024
|
Rothstein, Jeffrey D
|
|
|
24 |
1 |
p. 18-20
|
artikel
|
| 4 |
Advances in sleep research in 2024
|
Dauvilliers, Yves
|
|
|
24 |
1 |
p. 20-22
|
artikel
|
| 5 |
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
|
Benatar, Michael
|
|
|
24 |
1 |
p. 77-86
|
artikel
|
| 6 |
Autoimmune encephalitis: diagnostic challenges and tensions
|
Dale, Russell C
|
|
|
24 |
1 |
p. 5-6
|
artikel
|
| 7 |
Bridging the diagnostic gap in Alzheimer's disease
|
The Lancet Neurology,
|
|
|
24 |
1 |
p. 1
|
artikel
|
| 8 |
Carlyn Patterson Gentile
|
|
|
|
24 |
1 |
p. 27
|
artikel
|
| 9 |
Correction to Lancet Neurol 2024; 23: 1183–84
|
|
|
|
24 |
1 |
p. e1
|
artikel
|
| 10 |
Correction to Lancet Neurol 2024; 23: 1205–13
|
|
|
|
24 |
1 |
p. e1
|
artikel
|
| 11 |
Cristina Sampaio: bringing rigour to research in movement disorders
|
Samarasekera, Udani
|
|
|
24 |
1 |
p. 26
|
artikel
|
| 12 |
Diagnosis and management of status epilepticus: improving the status quo
|
Gettings, Jennifer V
|
|
|
24 |
1 |
p. 65-76
|
artikel
|
| 13 |
Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis
|
Olivé-Cirera, Gemma
|
|
|
24 |
1 |
p. 54-64
|
artikel
|
| 14 |
Epilepsy research highlights in 2024: avenues for discovery
|
Birbeck, Gretchen L
|
|
|
24 |
1 |
p. 13-15
|
artikel
|
| 15 |
Headache research in 2024: new data on migraine prevention
|
Pozo-Rosich, Patricia
|
|
|
24 |
1 |
p. 11-13
|
artikel
|
| 16 |
Highlights in traumatic brain injury research in 2024
|
Newcombe, Virginia
|
|
|
24 |
1 |
p. 10-11
|
artikel
|
| 17 |
Infectious diseases research in 2024: insights into dementia
|
Klein, Robyn S
|
|
|
24 |
1 |
p. 22-23
|
artikel
|
| 18 |
Ischaemic stroke in 2024: progress on multiple fronts
|
Yang, Pengfei
|
|
|
24 |
1 |
p. 7-8
|
artikel
|
| 19 |
Movement disorders in 2024: peripheral and outside the box
|
Mollenhauer, Brit
|
|
|
24 |
1 |
p. 15-16
|
artikel
|
| 20 |
Multiple sclerosis in 2024: evolving evidence and new hopes
|
Amato, Maria Pia
|
|
|
24 |
1 |
p. 17-18
|
artikel
|
| 21 |
Neurology takes centre stage at the Edinburgh Festival Fringe
|
Ranscombe, Peter
|
|
|
24 |
1 |
p. 30-31
|
artikel
|
| 22 |
Neuroscience research in 2024: advances in blood biomarkers and brain omics
|
Fu, Amy K Y
|
|
|
24 |
1 |
p. 24-25
|
artikel
|
| 23 |
Patrikios syndrome and SOD1 ALS
|
Andersen, Peter M
|
|
|
24 |
1 |
p. 27
|
artikel
|
| 24 |
Progress and future directions in spinal cord injury trials
|
Pedro, Karlo M
|
|
|
24 |
1 |
p. 3-5
|
artikel
|
| 25 |
Reconsidering prourokinase for acute ischaemic stroke
|
Turc, Guillaume
|
|
|
24 |
1 |
p. 2-3
|
artikel
|
| 26 |
Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial
|
Weidner, Norbert
|
|
|
24 |
1 |
p. 42-53
|
artikel
|
| 27 |
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
|
Li, Shuya
|
|
|
24 |
1 |
p. 33-41
|
artikel
|
| 28 |
Turning childhood experience of neurological disease into art
|
Moody, Joe
|
|
|
24 |
1 |
p. 32
|
artikel
|
Tijdschrift beschrijving